ITI Pharma and Healthcare Fund Regular vs Tata India Pharma & Healthcare Fund compare
ITI Pharma and Healthcare Fund Regular - Growth
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Chart Comparison
Overview
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Fund | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹233 Cr | ₹1325 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹100 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 08 Nov 2021 | 28 Dec 2015 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | NIFTY Healthcare TRI | Nifty Pharma TRI |
| Turn Over | % | 26.49% |
| Expense Ratio | 2.35 | 2.14 |
| Manager | Rohan Korde | Meeta Shetty |
| ISIN Code | INF00XX01BL5 | INF277K016A9 |
| Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 1 Month | -1.97% | -1.04% |
| 6 Month | 1.18% | 3.72% |
| 1 Year | -0.93% | 5.07% |
| 3 Year | 19.29% | 22.15% |
| 5 Year | - | 17.69% |
SIP Return Analysis
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 6 Month | -1.28% | 0.65% |
| 1 Year | 1.83% | 7.63% |
| 3 Year | 16.44% | 19.55% |
| 5 Year | - | 17.8% |
Rolling Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 1 Year | 18.94% | 8.89% |
| 3 Year | 20.21% | 18.72% |
| 5 Year | - | 15.51% |
Risk Management
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Standard Deviation | 15.64% | 16.04% |
| Sharp | 0.77% | 0.90% |
| Beta | 0.95% | 0.97% |
| Alpha | -2.74% | -0.83% |
Fund Managers
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Name | Rohan Korde | Meeta Shetty |
| Total AUM | ₹4626 Cr | ₹17847 Cr |
| Funds Managed | 10 | 5 |
| ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Market Cap
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Others | 3.94 | 3.86 |
| Large Cap | 32.04 | 22.93 |
| Mid Cap | 36.31 | 38.84 |
| Small Cap | 27.72 | 34.36 |
Sector Allocation
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Others | 1.7 | 1.5 |
| Healthcare | 93.14 | 96.33 |
| Basic Materials | 2.87 | 2.17 |
| Industrials | 1.05 | - |
| Financial Services | 1.25 | 0 |
Top Comparisons
WhiteOak Capital Balanced Advantage Fund Regular Plan Growth
3Y Returns0%
Axis Balanced Advantage Fund - Regular Plan - Growth
3Y Returns14.15%
Sundaram Mid Cap Fund Regular Plan - Growth
3Y Returns24.89%
HSBC Midcap Fund - Regular Growth
3Y Returns25.56%
BANDHAN Nifty 50 Index Fund - Regular Plan - Growth
3Y Returns12.78%
SBI Nifty Next 50 Index Fund - Regular Plan - Growth
3Y Returns17.67%
PGIM India Small Cap Fund - Regular Plan - Growth Option
3Y Returns13.38%
PGIM India Small Cap Fund - Regular Plan - Growth Option
3Y Returns13.38%